Literature DB >> 10359046

High-molecular-weight fibronectin synthesized by adenoid cystic carcinoma cells of salivary gland origin.

K Toyoshima1, S Kimura, J Cheng, Y Oda, K J Mori, T Saku.   

Abstract

To understand the morphogenesis of characteristic cribriform structures and the frequent invasion of salivary adenoid cystic carcinomas (ACC) along such basement membrane-rich structures as peripheral nerves, we have isolated fibronectin (FN) from the culture media of ACC3 cells established from a parotid ACC and characterized its glycosylation and alternative splicing status. FN isolated from ACC3 cells (ACC-FN) showed a molecular mass of 315 kDa in SDS-PAGE and was less heterogeneous and larger than plasma FN (pFN) or FNs from other cell sources. Differential enzymatic treatments of immunoprecipitated ACC-FN with neuraminidase, peptide-N-glycosidase F and endo-alpha-N-acetylgalactosaminidase revealed that ACC-FN was composed of a polypeptide chain of 270 kDa, with 10 kDa each of N-linked and O-linked oligosaccharide chains. Reverse transcription polymerase chain reaction (RT-PCR), in-situ hybridization, and immunofluorescence studies showed that most ACC-FNs contained ED-A, ED-B and IIICS regions in the molecules. This alternative splicing status of ACC-FN seemed to contribute to its less heterogeneous and larger molecular form. Cell attachment assay demonstrated that ACC-FN was more potent than pFN in adhesion of ACC3 cells. The results indicated that ACC-FN may function as a substrate for attachment of ACC3 cells, or that ACC3 cells trap and retain ACC-FN in their pericellular space. This isoform of FN may play an important role in the mode of invasion of ACC and the formation of stromal pseudocysts in the characteristic cribriform structure of ACC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359046      PMCID: PMC5926065          DOI: 10.1111/j.1349-7006.1999.tb00749.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


adenoid cystic carcinoma Coomassie brilliant blue Dulbecco's modified Eagle's medium enzyme‐linked immunosorbent assay fetal calf serum fibronectin heparan sulfate proteoglycan minimum essential medium phosphate‐buffered saline plasma FN peptide‐Nglycosidase reverse transcription‐polymerase chain reaction sodium dodecyl sulfatepolyacrylamide gel electrophoresis salt sodium citrate
  34 in total

1.  Distribution of fibronectin in the ectoderm of gastrulating chick embryos.

Authors:  D R Critchley; M A England; J Wakely; R O Hynes
Journal:  Nature       Date:  1979-08-09       Impact factor: 49.962

2.  Carbohydrate structure of galactoprotein a, a major transformation-sensitive glycoprotein released from hamster embryo fibroblasts.

Authors:  M Fukuda; S Hakomori
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Partial primary structure of bovine plasma fibronectin: three types of internal homology.

Authors:  T E Petersen; H C Thøgersen; K Skorstengaard; K Vibe-Pedersen; P Sahl; L Sottrup-Jensen; S Magnusson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

5.  Biosynthesis and processing of fibronectin in NIL.8 hamster cells.

Authors:  M G Choi; R O Hynes
Journal:  J Biol Chem       Date:  1979-12-10       Impact factor: 5.157

6.  Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver tumors.

Authors:  F Oyama; S Hirohashi; Y Shimosato; K Titani; K Sekiguchi
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

7.  Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactosamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen-binding domain: difference from human plasma fibronectin.

Authors:  B C Zhu; S F Fisher; H Pande; J Calaycay; J E Shively; R A Laine
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

8.  Biosynthesis of basement membrane molecules by salivary adenoid cystic carcinoma cells: an immunofluorescence and confocal microscopic study.

Authors:  J Cheng; T Irié; R Munakata; S Kimura; H Nakamura; R G He; A R Lui; T Saku
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Establishment of a human cancer cell line from carcinoma of the gingiva.

Authors:  M Koike; A Komori
Journal:  J Oral Pathol       Date:  1982-04

10.  Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.

Authors:  C Ffrench-Constant; L Van de Water; H F Dvorak; R O Hynes
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

View more
  4 in total

1.  Fibronectin molecular status determination useful to differentiate between rheumatoid arthritis and systemic lupus erythematosus patients.

Authors:  Magdalena Przybysz; Krzysztof Borysewicz; Iwona Kątnik-Prastowska
Journal:  Rheumatol Int       Date:  2012-01-04       Impact factor: 2.631

2.  Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.

Authors:  Yoshimasa Sumita; Manabu Yamazaki; Satoshi Maruyama; Tatsuya Abé; Jun Cheng; Ritsuo Takagi; Jun-Ichi Tanuma
Journal:  Oncol Rep       Date:  2018-08-22       Impact factor: 3.906

Review 3.  Salivary gland neoplasms.

Authors:  Terry A Day; John Deveikis; M Boyd Gillespie; John K Joe; Besim Ogretmen; J David Osguthorpe; Susan G Reed; Mary S Richardson; Michael Rossi; Ranjiv Saini; Anand K Sharma; Robert K Stuart
Journal:  Curr Treat Options Oncol       Date:  2004-02

4.  Immunophenotypical alterations with impact on the epithelial-mesenchymal transition (EMT) process in salivary gland adenoid cystic carcinomas.

Authors:  Iulia Cristiana Belulescu; Claudiu Mărgăritescu; Cristiana Iulia Dumitrescu; Maria Cristina Munteanu; Otilia Clara Mărgăritescu
Journal:  Rom J Morphol Embryol       Date:  2020       Impact factor: 1.033

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.